Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Martinotti

Showing results (101-110 of 482) with videos related to

Pageof 49
Sort By:
Comprehensive Psychiatry|May 7, 2013
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholicsGiovanni Martinotti, Marco Di Nicola, Daniela Tedeschi, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance DatabasesStefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, et al.
Frontiers in Psychiatry|December 19, 2014
Allostasis as a conceptual framework linking bipolar disorder and addictionMauro Pettorruso, Luisa De Risio, Marco Di Nicola, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 3, 2023
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?Giacomo d'Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, et al.
Brain Sciences|September 27, 2025
Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and OutcomesAlessio Mosca, Stefania Chiappini, Andrea Miuli, et al.
Schizophrenia Research. Cognition|September 11, 2025
Anomalous self-experience in schizophrenia spectrum disorders: Phenomenological and psychopathological correlatesAlessio Mosca, Stefania Chiappini, Arianna Pasino, et al.
Human Psychopharmacology|July 29, 2015
Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless productsRita Santacroce, Ornella Corazza, Giovanni Martinotti, et al.
CNS Spectrums|June 26, 2020
Substance-related exogenous psychosis: a postmodern syndromeGiovanni Martinotti, Luisa De Risio, Chiara Vannini, et al.
Addiction Biology|May 19, 2010
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptomsFrancesco Angelucci, Valerio Ricci, Giovanni Martinotti, et al.
Human Psychopharmacology|November 19, 2016
Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world studyPedro Damian Gargoloff, Ricardo Corral, Luis Herbst, et al.
Pageof 49

Showing results (101-110 of 482) with videos related to

Sort By:
Pageof 49
Comprehensive Psychiatry|May 7, 2013
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholicsGiovanni Martinotti, Marco Di Nicola, Daniela Tedeschi, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance DatabasesStefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, et al.
Frontiers in Psychiatry|December 19, 2014
Allostasis as a conceptual framework linking bipolar disorder and addictionMauro Pettorruso, Luisa De Risio, Marco Di Nicola, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 3, 2023
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?Giacomo d'Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, et al.
Brain Sciences|September 27, 2025
Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and OutcomesAlessio Mosca, Stefania Chiappini, Andrea Miuli, et al.
Schizophrenia Research. Cognition|September 11, 2025
Anomalous self-experience in schizophrenia spectrum disorders: Phenomenological and psychopathological correlatesAlessio Mosca, Stefania Chiappini, Arianna Pasino, et al.
Human Psychopharmacology|July 29, 2015
Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless productsRita Santacroce, Ornella Corazza, Giovanni Martinotti, et al.
CNS Spectrums|June 26, 2020
Substance-related exogenous psychosis: a postmodern syndromeGiovanni Martinotti, Luisa De Risio, Chiara Vannini, et al.
Addiction Biology|May 19, 2010
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptomsFrancesco Angelucci, Valerio Ricci, Giovanni Martinotti, et al.
Human Psychopharmacology|November 19, 2016
Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world studyPedro Damian Gargoloff, Ricardo Corral, Luis Herbst, et al.
Pageof 49